(Q31140389)

29 June 2017

Homocysteine and Real-Space Navigation Performance among Non-Demented Older Adults (English)

1 reference

29 June 2017

Martina Pařízková

1

1 reference

29 June 2017

Ross Andel

2

1 reference

29 June 2017

Ondřej Lerch

3

1 reference

29 June 2017

Hana Marková

4

1 reference

29 June 2017

Ivana Gažová

5

1 reference

29 June 2017

Martin Vyhnálek

6

1 reference

29 June 2017

Jakub Hort

7

1 reference

29 June 2017

Jan Laczó

8

1 reference

29 June 2017

11 October 2016

1 reference

Journal of Alzheimer's Disease

29 June 2017

1 reference

29 June 2017

55

1 reference

29 June 2017

3

1 reference

29 June 2017

951-964

1 reference

Neuropsychological deficits associated with route learning in Alzheimer disease, MCI, and normal aging.

29 June 2017

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

From Morris Water Maze to computer tests in the prediction of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Egocentric and allocentric memory as assessed by virtual reality in individuals with amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Human analogue of the morris water maze for testing subjects at risk of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Spatial Navigation in Preclinical Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Spatial navigation impairment is proportional to right hippocampal volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Effect of blood pressure on cognitive functions in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Cholesterol and cognitive performance among community volunteers from the Czech Republic.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Spatial memory impairments in a prediabetic rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Effect of western and high fat diets on memory and cholinergic measures in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Homocysteine and cognitive performance: modification by the ApoE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Homocysteine, white matter hyperintensities, and cognition in healthy elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Status of vitamins B-12 and B-6 but not of folate, homocysteine, and the methylenetetrahydrofolate reductase C677T polymorphism are associated with impaired cognition and depression in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Cognitive and neurochemical alterations in hyperhomocysteinemic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Differential effects of short- and long-term hyperhomocysteinaemia on cholinergic neurons, spatial memory and microbleedings in vivo in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood-brain barrier leakage in rats in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Synergistic effects of the MTHFR C677T polymorphism and hypertension on spatial navigation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Protein N-homocysteinylation: From cellular toxicity to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Spatial navigation testing discriminates two types of amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Spatial navigation and APOE in amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Measurement of functional activities in older adults in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Spatial navigation deficit in amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

In vivo and in vitro effects of homocysteine on Na+, K+-ATPase activity in parietal, prefrontal and cingulate cortex of young rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Hyperhomocysteinemia reduces glutamate uptake in parietal cortex of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

CSF phosphorylated tau protein and mild cognitive impairment: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160667

21 January 2018

Identifiers

0 references

1 reference